Page last updated: 2024-09-04

olmesartan and DDD MPGNII

olmesartan has been researched along with DDD MPGNII in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujigaki, Y; Fukasawa, H; Hishida, A; Huang, Y; Kitagawa, M; Misaki, T; Nakagawa, T; Nakamura, Y; Ohashi, N; Suzuki, F; Suzuki, H; Suzuki, S; Togawa, A; Yamamoto, T1
Fukuda, Y; Iino, Y; Ishizaki, M; Katayama, Y; Kawachi, H; Masuda, Y; Mii, A; Shimizu, A1
Ito-Ihara, T; Kita, T; Liu, N; Ono, T; Shimizu, S; Takagi, K1

Other Studies

3 other study(ies) available for olmesartan and DDD MPGNII

ArticleYear
Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antilymphocyte Serum; Blood Pressure; Gene Expression; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney; Male; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles

2008
Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Becaplermin; Biomarkers; Blood Pressure; Cell Proliferation; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Proteinuria; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Thy-1 Antigens

2009
Angiotensin II receptor blockade ameliorates mesangioproliferative glomerulonephritis in rats through suppression of CTGF and PAI-1, independently of the coagulation system.
    Nephron. Experimental nephrology, 2007, Volume: 105, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Coagulation; Connective Tissue Growth Factor; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Signal Transduction; Tetrazoles; Treatment Outcome

2007